PUBLIC CONTRACT · 2021
Prod Farmacêuticos do CPA 8 SPMS - 2021
- Contract value
- €50.00
- Signed on
- 26 January 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7588086PUBLISHED DESCRIPTION
CHPL _ 51000621 Prod Farmacêutic CPA 8 SPMS - 2021
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- MYLAN, LDo · Tax ID 502248793
- Bidder
- PROCLINICA-EQUIP. PROD. CLINICOS, LDA · Tax ID 500222665
- Bidder
- B. BRAUN MEDICAL, LDA. · Tax ID 501506543
- Bidder
- PMH PRODUTOS MEDIC. HOSPITAL, SA · Tax ID 502376899
- Bidder
- PAUL HARTMANN, LDA · Tax ID 502271728
- Bidder
- VYGON (PORTUGAL), LDA · Tax ID 503232785
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €50.00
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 26 March 2021
- Award date
- 26 January 2021
- Signing date
- 26 January 2021
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2019/8 - Antisséticos e desinfetantes de uso humano e produtos cosméticos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5009563
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.